1 Market Overview of Oligonucleotide Therapeutics 1.1 Oligonucleotide Therapeutics Market Overview 1.1.1 Oligonucleotide Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Oligonucleotide Therapeutics Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Oligonucleotide Therapeutics Market Size by Region (2015-2026) 1.4 Global Oligonucleotide Therapeutics Historic Market Size by Region (2015-2020) 1.5 Global Oligonucleotide Therapeutics Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) 1.6.1 North America Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) 1.6.2 Europe Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) 1.6.4 Latin America Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) 2 Oligonucleotide Therapeutics Market Overview by Type 2.1 Global Oligonucleotide Therapeutics Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Oligonucleotide Therapeutics Historic Market Size by Type (2015-2020) 2.3 Global Oligonucleotide Therapeutics Forecasted Market Size by Type (2021-2026) 2.4 Antisense Oligonucleotide 2.5 Aptamer 2.6 Other 3 Oligonucleotide Therapeutics Market Overview by Application 3.1 Global Oligonucleotide Therapeutics Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Oligonucleotide Therapeutics Historic Market Size by Application (2015-2020) 3.3 Global Oligonucleotide Therapeutics Forecasted Market Size by Application (2021-2026) 3.4 Neuromuscular Diseases 3.5 ATTR 3.6 Hepatic VOD 3.7 Other 4 Global Oligonucleotide Therapeutics Competition Analysis by Players 4.1 Global Oligonucleotide Therapeutics Market Size (Million US$) by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide Therapeutics as of 2019) 4.3 Date of Key Manufacturers Enter into Oligonucleotide Therapeutics Market 4.4 Global Top Players Oligonucleotide Therapeutics Headquarters and Area Served 4.5 Key Players Oligonucleotide Therapeutics Product Solution and Service 4.6 Competitive Status 4.6.1 Oligonucleotide Therapeutics Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Biogen 5.1.1 Biogen Profile 5.1.2 Biogen Main Business 5.1.3 Biogen Products, Services and Solutions 5.1.4 Biogen Revenue (US$ Million) & (2015-2020) 5.1.5 Biogen Recent Developments 5.2 Sarepta Therapeutics 5.2.1 Sarepta Therapeutics Profile 5.2.2 Sarepta Therapeutics Main Business and Company’s Total Revenue 5.2.3 Sarepta Therapeutics Products, Services and Solutions 5.2.4 Sarepta Therapeutics Revenue (US$ Million) (2015-2020) 5.2.5 Sarepta Therapeutics Recent Development and Reaction to Covid-19 5.3 Jazz Pharmaceuticals 5.5.1 Jazz Pharmaceuticals Profile 5.3.2 Jazz Pharmaceuticals Main Business 5.3.3 Jazz Pharmaceuticals Products, Services and Solutions 5.3.4 Jazz Pharmaceuticals Revenue (US$ Million) & (2015-2020) 5.3.5 Bausch & Lomb Recent Developments 5.4 Bausch & Lomb 5.4.1 Bausch & Lomb Profile 5.4.2 Bausch & Lomb Main Business 5.4.3 Bausch & Lomb Products, Services and Solutions 5.4.4 Bausch & Lomb Revenue (US$ Million) & (2015-2020) 5.4.5 Bausch & Lomb Recent Developments 5.5 Alnylam Pharmaceuticals 5.5.1 Alnylam Pharmaceuticals Profile 5.5.2 Alnylam Pharmaceuticals Main Business 5.5.3 Alnylam Pharmaceuticals Products, Services and Solutions 5.5.4 Alnylam Pharmaceuticals Revenue (US$ Million) & (2015-2020) 5.5.5 Alnylam Pharmaceuticals Recent Developments 5.6 Dynavax Technologies 5.6.1 Dynavax Technologies Profile 5.6.2 Dynavax Technologies Main Business 5.6.3 Dynavax Technologies Products, Services and Solutions 5.6.4 Dynavax Technologies Revenue (US$ Million) & (2015-2020) 5.6.5 Dynavax Technologies Recent Developments 5.7 Kastle therapeutics 5.7.1 Kastle therapeutics Profile 5.7.2 Kastle therapeutics Main Business and Company’s Total Revenue 5.7.3 Kastle therapeutics Products, Services and Solutions 5.7.4 Kastle therapeutics Revenue (US$ Million) (2015-2020) 5.7.5 Kastle therapeutics Recent Development and Reaction to Covid-19 5.8 Akcea Therapeutics 5.8.1 Akcea Therapeutics Profile 5.8.2 Akcea Therapeutics Main Business 5.8.3 Akcea Therapeutics Products, Services and Solutions 5.8.4 Akcea Therapeutics Revenue (US$ Million) & (2015-2020) 5.8.5 Akcea Therapeutics Recent Developments 6 North America 6.1 North America Oligonucleotide Therapeutics Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Oligonucleotide Therapeutics Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Oligonucleotide Therapeutics Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Oligonucleotide Therapeutics Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Oligonucleotide Therapeutics Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Oligonucleotide Therapeutics Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Oligonucleotide Therapeutics Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Oligonucleotide Therapeutics Market Size by Region (2015-2020) (US$ Million) Table 3. Global Oligonucleotide Therapeutics Market Size Share by Region (2015-2020) Table 4. Global Oligonucleotide Therapeutics Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Oligonucleotide Therapeutics Forecasted Market Size Share by Region (2021-2026) Table 6. Global Oligonucleotide Therapeutics Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Oligonucleotide Therapeutics Market Size by Type (2015-2020) (US$ Million) Table 8. Global Oligonucleotide Therapeutics Revenue Market Share by Type (2015-2020) Table 9. Global Oligonucleotide Therapeutics Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Oligonucleotide Therapeutics Revenue Market Share by Type (2021-2026) Table 11. Global Oligonucleotide Therapeutics Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Oligonucleotide Therapeutics Market Size by Application (2015-2020) (US$ Million) Table 13. Global Oligonucleotide Therapeutics Revenue Market Share by Application (2015-2020) Table 14. Global Oligonucleotide Therapeutics Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Oligonucleotide Therapeutics Revenue Market Share by Application (2021-2026) Table 16. Global Oligonucleotide Therapeutics Revenue (US$ Million) by Players (2015-2020) Table 17. Global Oligonucleotide Therapeutics Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide Therapeutics as of 2019) Table 19. Date of Key Manufacturers Enter into Oligonucleotide Therapeutics Market Table 20. Global Oligonucleotide Therapeutics Top Players Headquarters and Area Served Table 21. Oligonucleotide Therapeutics Product Solution and Service Table 22. Global Oligonucleotide Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Biogen Basic Information List Table 25. Biogen Description and Business Overview Table 26. Biogen Oligonucleotide Therapeutics Products, Services and Solutions Table 27. Revenue (Million US$) in Oligonucleotide Therapeutics Business of Biogen (2015-2020) Table 28. Biogen Recent Developments Table 29. Sarepta Therapeutics Basic Information List Table 30. Sarepta Therapeutics Description and Business Overview Table 31. Sarepta Therapeutics Oligonucleotide Therapeutics Products, Services and Solutions Table 32. Revenue (Million US$) in Oligonucleotide Therapeutics Business of Sarepta Therapeutics (2015-2020) Table 33. Sarepta Therapeutics Recent Developments Table 34. Jazz Pharmaceuticals Basic Information List Table 35. Jazz Pharmaceuticals Description and Business Overview Table 36. Jazz Pharmaceuticals Oligonucleotide Therapeutics Products, Services and Solutions Table 37. Revenue (Million US$) in Oligonucleotide Therapeutics Business of Jazz Pharmaceuticals (2015-2020) Table 38. Jazz Pharmaceuticals Recent Developments Table 39. Bausch & Lomb Basic Information List Table 40. Bausch & Lomb Description and Business Overview Table 41. Bausch & Lomb Oligonucleotide Therapeutics Products, Services and Solutions Table 42. Revenue (Million US$) in Oligonucleotide Therapeutics Business of Bausch & Lomb (2015-2020) Table 43. Bausch & Lomb Recent Developments Table 44. Alnylam Pharmaceuticals Basic Information List Table 45. Alnylam Pharmaceuticals Description and Business Overview Table 46. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Products, Services and Solutions Table 47. Revenue (Million US$) in Oligonucleotide Therapeutics Business of Alnylam Pharmaceuticals (2015-2020) Table 48. Alnylam Pharmaceuticals Recent Developments Table 49. Dynavax Technologies Basic Information List Table 50. Dynavax Technologies Description and Business Overview Table 51. Dynavax Technologies Oligonucleotide Therapeutics Products, Services and Solutions Table 52. Revenue (Million US$) in Oligonucleotide Therapeutics Business of Dynavax Technologies (2015-2020) Table 53. Dynavax Technologies Recent Developments Table 54. Kastle therapeutics Basic Information List Table 55. Kastle therapeutics Description and Business Overview Table 56. Kastle therapeutics Oligonucleotide Therapeutics Products, Services and Solutions Table 57. Revenue (Million US$) in Oligonucleotide Therapeutics Business of Kastle therapeutics (2015-2020) Table 58. Kastle therapeutics Recent Developments Table 59. Akcea Therapeutics Basic Information List Table 60. Akcea Therapeutics Description and Business Overview Table 61. Akcea Therapeutics Oligonucleotide Therapeutics Products, Services and Solutions Table 62. Revenue (Million US$) in Oligonucleotide Therapeutics Business of Akcea Therapeutics (2015-2020) Table 63. Akcea Therapeutics Recent Developments Table 64. North America Oligonucleotide Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 65. North America Oligonucleotide Therapeutics Market Size Share by Country (2015-2020) Table 66. Europe Oligonucleotide Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 67. Europe Oligonucleotide Therapeutics Market Size Share by Country (2015-2020) Table 68. Asia-Pacific Oligonucleotide Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 69. Asia-Pacific Oligonucleotide Therapeutics Market Size Share by Country (2015-2020) (US$ Million) Table 70. Latin America Oligonucleotide Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 71. Latin America Oligonucleotide Therapeutics Market Size Share by Country (2015-2020) (US$ Million) Table 72. Middle East & Africa Oligonucleotide Therapeutics Market Size by Players (2015-2020) (US$ Million) Table 73. Middle East & Africa Oligonucleotide Therapeutics Market Size Share by Players (2015-2020) (US$ Million) Table 74. Oligonucleotide Therapeutics Market Trends Table 75. Oligonucleotide Therapeutics Market Drivers Table 76. Oligonucleotide Therapeutics Market Challenges Table 77. Oligonucleotide Therapeutics Market Restriants Table 78. Research Programs/Design for This Report Table 79. Key Data Information from Secondary Sources Table 80. Key Data Information from Primary Sources List of Figures Figure 1. Global Oligonucleotide Therapeutics Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Oligonucleotide Therapeutics Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Oligonucleotide Therapeutics Market Share by Regions: 2020 VS 2026 Figure 4. North America Oligonucleotide Therapeutics Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Oligonucleotide Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Oligonucleotide Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Oligonucleotide Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Oligonucleotide Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Oligonucleotide Therapeutics Market Share by Type in 2020 & 2026 Figure 10. Antisense Oligonucleotide Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. Aptamer Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Other Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Global Oligonucleotide Therapeutics Market Size Share by Application in 2020 & 2026 Figure 14. Neuromuscular Diseases Market Size (US$ Million) YoY Growth (2015-2026) Figure 15. ATTR Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Hepatic VOD Market Size (US$ Million) YoY Growth (2015-2026) Figure 17. Other Market Size (US$ Million) YoY Growth (2015-2026) Figure 18. Oligonucleotide Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Top 5 and Top 10 Players Oligonucleotide Therapeutics Market Share in 2019 Figure 20. United States Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Canada Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Germany Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. France Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. U.K. Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Italy Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Russia Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Nordic Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Rest of Europe Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. China Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Japan Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. South Korea Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Southeast Asia Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. India Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Australia Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Rest of Asia-Pacific Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Mexico Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Brazil Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Rest of Latin America Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Turkey Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Saudi Arabia Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. UAE Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Middle East & Africa Oligonucleotide Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation

Biogen Sarepta Therapeutics Jazz Pharmaceuticals Bausch & Lomb Alnylam Pharmaceuticals Dynavax Technologies Kastle therapeutics Akcea Therapeutics